CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 93 filers reported holding CYTOSORBENTS CORP in Q4 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $116,430 | -47.6% | 61,931 | 0.0% | 0.00% | – |
| Q2 2023 | $222,332 | +7.3% | 61,931 | +0.7% | 0.00% | – |
| Q1 2023 | $207,231 | +113.9% | 61,493 | -1.6% | 0.00% | – |
| Q4 2022 | $96,860 | +16.7% | 62,490 | +1.9% | 0.00% | – |
| Q3 2022 | $83,000 | -38.1% | 61,339 | +0.6% | 0.00% | – |
| Q2 2022 | $134,000 | -27.2% | 60,977 | +5.7% | 0.00% | – |
| Q1 2022 | $184,000 | -7.5% | 57,684 | +21.3% | 0.00% | – |
| Q4 2021 | $199,000 | – | 47,543 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 450,000 | $1,616 | 1.58% |
| Skylands Capital, LLC | 2,793,470 | $10,028,557 | 1.44% |
| Sargent Investment Group, LLC | 1,289,546 | $4,629,470 | 1.12% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 237,940 | $854,205 | 0.96% |
| Avenir Corp | 2,719,732 | $9,763,838 | 0.86% |
| Granahan Investment Management | 1,616,587 | $5,803,547 | 0.18% |
| Seelaus Asset Management LLC | 20,450 | $73 | 0.06% |
| Cowen Prime Advisors LLC | 42,301 | $151,861 | 0.05% |
| HighMark Wealth Management LLC | 10,000 | $35,900 | 0.03% |
| Key Client Fiduciary Advisors, LLC | 12,000 | $43,080 | 0.02% |